Autopsy report · NCT01197963

A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2

“IRB temporarily halted enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 5 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

The University of Texas Health Science Center, Houston

Sponsor type

University, hospital or other

Conditions

Type 2 Diabetes Mellitus

Interventions

Sleeve Gastrectomy and Ileal transposition; dietary and medical management

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Dexmedetomidine Cycling and Sleep in the Pediatric ICU
  “No enrollment, IRB closed” (84% match in meaning)
• Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
  “IRB approval not renewed/approval lapsed. Prior status: insufficient enrollment; study suspended pending analysis” (82% match in meaning)
• Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
  “Study halted prematurely; IRB approval not obtained” (75% match in meaning)
• Adherence to Otezla
  “Terminated IRB approval 6/26/2024, study was never initiated or activated” (74% match in meaning)
• Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
  “Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to resume in the future. This is not a suspension of IRB approval.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.